TARDBP and amyotrophic lateral sclerosis: Recently Patten et al (2017) performed a phenotypic drug screening of an approved drug compound library containing 3,850 molecules on C. elegans transgenics-expressing mutant TDP-43 (a protein mutated in ALS patients).